Elliott Investment Management reported a major stake in Tokyo Gas Co. as activist investors increasingly seek to unlock ...

Shinkansen Route from Aomori to Hakodate I was booked for two nights in Hakodate before going on to Sapporo for my final week ...

Tokyo is poised to roll out a long-awaited stimulus package that will enable Japanese firms to gain global share in the ...

EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

Chinese President Xi Jinping told Japanese Prime Minister Shigeru Ishiba in their first meeting that China hoped Japan would ...

Japan is seeing a record boom in tourism, but one recent visitor travelled more than the circumference of the earth to get ...

Steve Lee Hayes carved letters onto a pillar of a gate of a shrine in Shibuya and was arrested on suspicion of property ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

An estimated 4,500 prescriptions have been filled in 2024 so far, Iwatsubo said. About 80 percent of patients have mild cognitive impairment, the rest have mild dementia. Most are in their 70s, and ...

A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan targeting proteins ...

Tokyo, Nov. 13 (Jiji Press)--Japan's Central Social Insurance Medical Council, which advises the health minister, approved ...